Thai Beverage PCL
F:T6W
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Thai Beverage PCL
F:T6W
|
TH |
|
O
|
OrthoPediatrics Corp
F:2X7
|
US |
|
R
|
Renovaro Biosciences Inc
NASDAQ:RENB
|
US |
|
Royalty Pharma PLC
F:RPD
|
US |
|
B
|
Broadridge Financial Solutions Inc
F:5B9
|
US |
|
A
|
Acasti Pharma Inc
NASDAQ:ACST
|
CA |
Wall St Price Targets
T6W Price Targets Summary
Thai Beverage PCL
According to Wall Street analysts, the average 1-year price target for T6W is 0.41 EUR with a low forecast of 0.3 EUR and a high forecast of 0.5 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is T6W's stock price target?
Price Target
0.41
EUR
According to Wall Street analysts, the average 1-year price target for T6W is 0.41 EUR with a low forecast of 0.3 EUR and a high forecast of 0.5 EUR.
What is the Revenue forecast for Thai Beverage PCL?
Projected CAGR
4%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Thai Beverage PCL?
Projected CAGR
0%
Over the last 8 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Thai Beverage PCL?
Projected CAGR
7%
Over the last 8 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 3 years is 7%.
